Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03891979
Title Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma
Recruitment Withdrawn
Gender both
Phase FDA approved
Variant Requirements No
Sponsors New York University School of Medicine
Indications

pancreatic adenocarcinoma

Therapies

Ciprofloxacin

Metronidazole

Pembrolizumab

Age Groups: senior | adult | child
Covered Countries USA


No variant requirements are available.